Daily peanut intake improved insulin responsiveness in memory circuits

Eating peanuts every day was linked to measurable changes inside brain regions tied to memory in healthy older adults. In a 16-week randomized controlled crossover trial, 31 adults ages 60 to 75 who ate 60 grams of unsalted, skin-roasted peanuts daily showed improved insulin responsiveness in a cluster of right-hemisphere regions associated with memory processing. The affected areas included portions of the lingual gyrus, hippocampus, parahippocampal gyrus, and posterior cingulate gyrus.

The signal is biologically plausible. Insulin does more than regulate glucose in the bloodstream; in the brain, it helps neurons grow, survive, and communicate. As insulin signaling weakens with age, memory-related networks may become less efficient, and that vulnerability has been linked to cognitive decline and processes associated with Alzheimer’s disease. A dietary change that improves regional insulin responsiveness therefore matters far beyond nutrition headlines.

A crossover design put each participant on both sides of the comparison

The trial used a randomized, controlled crossover structure, giving each participant a period of peanut consumption and a period of peanut avoidance. That design strengthens the internal comparison because every participant serves as his or her own control, reducing the noise that comes from between-person differences in diet, body composition, and baseline brain function. During the peanut phase, participants received premeasured packets and were instructed to eat them in the morning or afternoon, either all at once or divided across the day.

The control phase required complete peanut avoidance. After 16 weeks, participants switched conditions, allowing investigators to compare brain measures under both dietary patterns. This was not a short-term snack study; it was a months-long intervention built to detect physiologic changes rather than fleeting post-meal effects.

Brain imaging captured a regional response, not just a general trend

To measure the brain’s response to insulin, the team used arterial spin labeling magnetic resonance imaging, or ASL-MRI, and tracked changes in regional cerebral blood flow after insulin was administered through the nose. That approach allowed investigators to assess whether specific brain areas became more or less responsive to insulin signaling after the dietary intervention.

The result was not a diffuse, whole-brain shift. Improved responsiveness appeared in a defined set of regions on the right side, including the hippocampus and parahippocampal gyrus, structures central to encoding and retrieving memory. The posterior cingulate gyrus also participated in the response, along with the lingual gyrus. In practical terms, the study points to a targeted effect in networks that are already known to be vulnerable in aging and neurodegenerative disease.

One sentence captures the clinical weight of the finding: the brain’s response to insulin improved in memory circuitry after a simple dietary exposure.

Why peanuts could influence the aging brain

The study does not reduce the effect to a single nutrient. Peanuts contain unsaturated fats, dietary fiber, vitamins, minerals, plant protein, and bioactive phytochemicals, all of which may contribute to metabolic and vascular effects that reach the brain. They are also rich in L-arginine, a precursor of nitric oxide. Nitric oxide supports vascular tone and has been linked to learning and memory performance, giving the peanut intervention a mechanistic route through both metabolism and blood flow.

That broader biology fits with earlier work from the same group. A 2025 trial found that 16 weeks of peanut consumption increased overall cerebral blood flow by 3.6% and improved verbal memory performance by 5.8%. The newer findings extend that story by showing a specific improvement in insulin responsiveness within memory-related regions, not merely a global circulation effect.

What was measured beyond insulin signaling

The protocol reached beyond brain imaging. Investigators also used abdominal MRI to measure intrahepatic lipid content, a marker of fat accumulation in the liver, and they administered the Cambridge Neuropsychological Test Automated Battery to assess cognition. Those measures matter because brain insulin action does not exist in isolation; it sits at the intersection of metabolic health, vascular function, and cognitive performance.

Even so, the trial report centers on the regional insulin findings rather than claiming a broad clinical benefit. That restraint is appropriate. Healthy older adults do not instantly translate into patients with cognitive impairment, and improved brain insulin responsiveness is a mechanistic endpoint, not a diagnosis or a treatment effect on its own.

What the finding can and cannot support today

This trial involved just 31 healthy adults, all between 60 and 75 years old. The sample is small, and the intervention was limited to a specific peanut preparation: unsalted, skin-roasted peanuts delivered in fixed daily portions. Those details matter because they narrow the result to one exact dietary strategy rather than to peanuts in general, and certainly not to every nut product or snack formulation on the market.

The findings also leave open a crucial clinical question: whether the same brain changes would appear in people with mild cognitive impairment, diabetes, obesity, or established neurodegenerative disease. The study supports a biologically credible pathway, but it does not prove that daily peanut intake prevents dementia or reverses cognitive decline. It does, however, strengthen the argument that metabolic signaling in the aging brain remains modifiable through diet.

For clinicians and readers alike, the most concrete takeaway is straightforward. A modest daily serving of unsalted, skin-roasted peanuts was associated with better brain insulin responsiveness in older adults, especially in regions tied to memory. The next step is not speculation about miracle foods; it is testing whether this regional signal translates into durable cognitive benefit in larger and more diverse populations.


Reporting by Dr. A. Manasa, MBBS for Medicine World Foundation, with additional data provided by ScienceDaily Health & Medicine.